thirty years ago michel m henry n wagner jr wrote article published nucleonics cyclotron production isotopes biomedical research report use nucleonics paper framework relate predictions current state art broken key areas commercially available cyclotrons costs operating cyclotron facilities emergence compact accelerators cyclotron production radionuclides therapeutic applications companies producing cyclotrons commercially general electric medical systems cti cyclotron systems ebco iba instruments japan steel works majority machines negative ion systems allows option dual irradiation targets modular design allows customed particular facilitys need cyclotron facility costs increased dramatically NUMBER determined bulk increase lies costs establish staff facility increased regulation federal state organizations severely impacted operational expenses growing demand pet radiopharmaceuticals clinical arena increased staffing requirements facility surprisingly costs cyclotrons increased terms real dollars especially considers greater sophistication target design automation computer control occurred time innovative approaches taken develop low energy accelerators capable producing pet isotopes easier operate expensive commercially available cyclotrons systems developed gained commercial recognition number groups begun address production longer lived isotopes biomedical cyclotrons development technology help progress targeted radiotherapy present overview potentially useful isotopes ter pogossian long lived nnk oxford